ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $99,000 | -93.8% | 31,298 | -94.9% | 0.01% | -81.8% |
| Q4 2016 | $1,594,000 | -71.9% | 613,231 | -57.9% | 0.06% | -70.3% |
| Q3 2016 | $5,663,000 | +46.3% | 1,455,676 | +1.2% | 0.18% | +31.2% |
| Q2 2016 | $3,870,000 | -14.7% | 1,438,736 | -2.3% | 0.14% | -14.5% |
| Q1 2016 | $4,535,000 | -22.3% | 1,472,456 | -2.9% | 0.16% | -17.9% |
| Q4 2015 | $5,837,000 | +9.6% | 1,516,146 | -13.1% | 0.20% | +21.8% |
| Q3 2015 | $5,324,000 | -20.6% | 1,745,604 | +10.3% | 0.16% | -13.2% |
| Q2 2015 | $6,709,000 | +13.8% | 1,582,237 | +3.6% | 0.19% | +12.4% |
| Q1 2015 | $5,897,000 | -43.2% | 1,527,837 | -0.9% | 0.17% | -44.2% |
| Q4 2014 | $10,378,000 | +21.2% | 1,541,984 | -1.1% | 0.30% | +14.8% |
| Q3 2014 | $8,562,000 | -6.4% | 1,559,623 | +74.8% | 0.26% | -1.1% |
| Q2 2014 | $9,143,000 | -20.0% | 892,023 | -6.2% | 0.27% | -13.3% |
| Q1 2014 | $11,422,000 | +27.4% | 951,018 | +19.9% | 0.31% | +33.3% |
| Q4 2013 | $8,967,000 | +77.6% | 792,878 | +69.3% | 0.23% | +72.4% |
| Q3 2013 | $5,049,000 | – | 468,378 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |